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Abstract
OBJECTIVES: Surgical repair of aneurysmal disease involving the ascending aorta, aortic arch and eventually the descending aorta is gen-
erally associated with significant morbidity and mortality. A less invasive approach with the ascending wrapping technique (WT), supra-
aortic vessel debranching (SADB) and thoracic endovascular aneurysm repair (TEVAR) in zone 0 was developed to reduce the associated
risk in these patients.
METHODS: During a 10-year period, consecutive patients treated by the ascending WT, SADB and TEVAR in zone 0 were included. All pa-
tients were considered at high risk for conventional surgery. Measured outcomes included perioperative deaths and morbidity, maximal
aortic transverse diameter (TD) and its postoperative evolution, endoleak, survival, freedom from cardiovascular reinterventions, SADB
freedom from occlusion and aortic valve function during follow-up. Median follow-up was 37.4 [mean = 34; range, 0–65; standard devi-
ation (SD) = 20] months.
RESULTS: Twenty-six cases were included with a mean age of 71.88 (r = 56–87; SD = 8) years. A mean of 2.9 supra-aortic vessels (75) per
patient was debranched from the ascending aorta. The mean time interval from WT/SADB and TEVAR was 29 (r = 0–204; SD = 48) days.
TEVAR was associated with chimney and/or periscope grafts in 6 (23%) patients, and extra-anatomical supra-aortic bypasses were per-
formed in 6 (23%) patients. Perioperative mortality was 7.7% (2/26). Neurological events were registered in 3 (11.5%) cases, and a reinter-
vention was required in 3 (11.5%) cases. After the WT, the ascending diameter remained stable during the follow-up period in all cases. At
mean follow-up, significant shrinkage of the arch/descending aorta diameter was observed. A type I/III endoleak occurred in 3 cases. At
5 years, the rates of survival, freedom from cardiovascular reinterventions and SADB freedom from occlusion were 71.7, 82.3 and 96%,
respectively.
CONCLUSIONS: The use of the ascending WT, SADB and TEVAR in selected patients with complex thoracic aorta disease is safe and shows
promising mid-term results at 3 years. The combination of these techniques could represent an alternative to the standard open surgical
repair, especially in older patients or in patients unfit for cardiopulmonary bypass.
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INTRODUCTION
Thoracic aortic disease is found in 10.4 persons per 100 000 per-
son years [1]. Thoracic aortic aneurysms involve the ascending
aorta in approximately 60% of cases, the aortic arch in 10%, the
descending aorta in 40% and the thoracoabdominal aorta in the
remaining 10% [2]. According to EuroSCORE.org, the mortality
rate for open surgical thoracic aorta repair ranges from 2 to 50%,
depending on age, risk factors, redo situation and nonelective
setting [3]. This finding might be explained by the fact that
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treatment of the ascending aorta and/or arch generally requires
aortic replacement with cardiopulmonary bypass (CPB) and
circulatory arrest, eventually combined with deep hypothermia
[4, 5].
Recently, in patients presenting with an aneurysm involving
the aortic arch and the appropriate proximal landing zone in the
ascending aorta, thoracic endovascular aneurysm repair (TEVAR)
with fenestrated or branched devices eventually combined with
rerouting/debranching of the supra-aortic trunks was an attract-
ive alternative to conventional open repair. However, in patients
with a dilated or aneurysmal ascending aorta, a stent-graft land-
ing in zone 0 may not be possible or safe. Generally, this popula-
tion is treated with ascending and arch replacement or
ascending replacement combined with hybrid techniques and/or
grafts [6]. To avoid cardiopulmonary bypass and/or eventual
circulatory arrest in such patients, the ascending wrapping tech-
nique (WT) with supra-aortic vessel debranching (SADB) may
allow safe and durable TEVAR extending to zone 0. We report
herein our results with this technique.
METHODS
From November 2006 to August 2015, data from patients treated
by the ascending WT, SADB and TEVAR in zone 0 were obtained
from the clinical information system of the University Hospital of
Zurich (KISIM 4.901; Dendrite, Dendrite Clinical System, Henley-
on-Thames, UK). Indications for treatment were aortic (arch and/
or ascending) disease requiring zone 0 TEVAR proximal landing
and high-risk profile for conventional surgery (graft replacement)
with a EuroSCORE >5% and/or presenting multifocal aneurysm
locations. The indication for the ascending WT was an ascending
transverse diameter (TD) of >38 mm (small aneurysm considered
inappropriate for safe tangential-clamping/debranching and
stent-graft landing/sealing) and <70 mm (large aneurysms at high
risk of dissection and rupture if addressed off-pump during the
WT). All patients were considered at high surgical risk. As re-
ported by Andersen et al. [6], comorbidities (age >65 years, cor-
onary artery disease, heart failure, chronic obstructive disease
and renal function impairment) and anatomical characteristics
(thoracosternotomy incision and two-stage open repair) were
considered to define high-risk patients. Interventions were
planned after reviewing CT angiographic scans from all patients.
Demographic and clinical data were collected, including the
EuroSCORE II risk mode [3]. The New York Heart Association
(NYHA) [7] heart function (especially left ventricular function) and
the Global Initiative for Chronic Obstructive Lung Disease
(GOLD) were used to assess cardiac and respiratory function [8].
Outcome measures included perioperative mortality and mor-
bidity rates, retrograde type A dissection, maximal aortic TD and
its postoperative evolution, endoleak, survival, freedom from car-
diovascular reinterventions, SADB freedom from occlusion and
aortic valve function during follow-up. Informed consent about
the procedure itself and the anonymous data collection and ana-
lysis was obtained from all patients.
Follow-up consisted of a clinical examination, CTA and echo-
cardiography performed yearly. In case of endoleak with a stable
or reduced aneurysm sac, the follow-up with clinical examination
and computed tomography angiographic and echocardiographic
scans was repeated every 6 months. In case of an increase in sac
diameter, imaging follow-up was performed within 3 months. If
growth was detected again, a redo procedure was performed.
Median follow-up was 37.4 [mean: 34; range: 0–65; standard de-
viation (SD) = 20] months.
Statistical analysis
Means and SD or median and range were reported for paramet-
ric data; absolute values and percentages, for non-parametric
data. Differences in preoperative and postoperative maximal aor-
tic TD were assessed using the t-test. Kaplan–Meier curves were
used to estimate survival and freedom from cardiovascular rein-
terventions. Statistical significance was considered P < 0.05. For
Kaplan–Meier curves, confidence intervals (CI) and standard
errors exceeding 10% were reported. Statistical analysis was per-
formed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
Technique
Both the WT and SADB were carried out in the same operation
through a full median sternotomy to achieve an ascending ex-
posure from the sinotubular junction to the brachiocephalic
trunk (BCT) or eventually to the origin of the left common carotid
artery.
As previously reported [9], the WT was performed with a poly-
propylene or polyester mesh that was marked before its use to
achieve the final transverse aortic circumference by multiplying
the intended aortic diameter by 3.14 (p). The marked mesh was
placed around the ascending aorta and fixed to the posterior
aortic wall with two proximal anchoring stitches (Ticron 4.0) just
above the coronary sinuses. The mesh was then sutured, in cor-
respondence with the marked lines, with a polypropylene 3.0
running suture (Blalock suture technique). A second suture line
fixing the mesh to the aortic wall was subsequently placed with
additional distal anchoring stitches (Fig. 1). During the WT, trans-
oesophageal echocardiography was used routinely to assess the
heart and valve function. Generally, the WT was intended to
achieve a final ascending TD of about 35 to 38 mm (15–30%
diameter reduction).
The SABD was performed after the ascending WT. The
wrapped ascending aorta was tangentially clamped with a De
Bakey multipurpose clamp in correspondence with the anterior
or lateral wall to perform the proximal end-to-side anastomosis.
A longitudinal incision involving both the mesh and the ascend-
ing aorta was made to perform the proximal anastomosis.
According to the diameter used for the SADB conduit, an incision
of proper length was made. The SADB conduit suture involved
both the ascending aorta and the wrapping mesh in order to ob-
tain the best fixation (Fig. 2). In cases of multiple SADB, the prox-
imal anastomosis was eventually constructed with a Y-shaped
Dacron graft in an end-to-side fashion; in the case of a single
SADB, a straight Dacron or polytetrafluoroethylene graft was
used. A radiopaque metallic marker (external pacemaker wire)
was placed in relation to the proximal anastomosis to identify
the debranching graft during the TEVAR proximal landing.
Distal anastomoses were constructed end to side or with the
ViaBahn Open Revascularisation TEChnique (VORTEC). Generally,
the end-to-side anastomosis was used to debranch the BCT; the
VORTEC was used for single vessel end-to-end debranching [10].
The Gore hybrid vascular graft (GHVG; W. L. Gore & Associates,
Flagstaff, AR) was used in a single vessel with the same technique
used for the visceral vessel [11]. TEVAR was occasionally performed
during the same operation after the WT/SADB or more commonly
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in a delayed secondary procedure. An extra-stiff wire was passed
through a femoral access point to reach the aortic valve. The stent
graft was advanced over the wire and placed at the level of the as-
cending aorta (zone 0). The proximal landing zone was identified
by the radiopaque marker placed during the SADB without the
need for angiography. A 15 to 25% oversized aortic stent graft was
used for proximal landing in correspondence of the wrapped as-
cending aorta. The size for the wrapped ascending stent graft was
available from the operative report and the post-operative CTA.
The aortic stent graft was deployed, and angiography was per-
formed at the completion of the procedure. Chimney and/or peri-
scope grafts (CPG) were eventually placed in the supra-aortic
branches during the TEVAR procedure (Fig. 3) [12, 13]. CPG were
used to reduce the operative time during the WT/SADB in specific
circumstances such as the involvement of supra-aortic vessel scar
tissue, an anatomical anomaly or a left subclavian artery (LSA)–
right subclavian artery not easily reached from a median sternot-
omy due to aneurysm remodelling or contained rupture.
Generally, TEVAR was performed under local anaesthesia.
RESULTS
We treated a total of 26 cases with a mean age of 71.88 (r = 56–
87; SD = 8) years. Comorbidities and risk factors are reported in
Table 1.
Twenty-three (89%) patients presented with multiple areas of
aortic disease; 7 (27%) interventions were performed emergently.
An ascending aneurysm not allowing a stent graft landing (diam-
eter >42–65 mm) was diagnosed in 23 (89%); an ascending dila-
tion not fitting the safe stent graft landing and/or sealing (up to
42 mm) was diagnosed in the other 3 (11%). An arch aneurysm
was present in 15 (58%); a descending aortic aneurysm, in 5
(19%); a Crawford type I thoracoabdominal aneurysm (TAAA), in
Figure 2: Supra-aortic debranching. A De Bakey multipurpose clamp is placed
along the anterior or lateral wall of the ascending aorta to perform the prox-
imal anastomosis.
Figure 3: A computed tomography angiogram after TEVAR showing the prox-
imal landing zone in relation to the ascending aorta, a periscope graft in the left
subclavian artery and regular patency of the supra-aortic debranching.
Figure 1: Wrapping technique. The polypropylene mesh is placed around the
ascending aorta after its fixation to the posterior aortic wall with two proximal
anchoring stitches (Ticron 4.0). The first polypropylene 3.0 running suture
(Blalock suture technique) is placed.
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2 (8%); a Crawford type II TAAA, in 7 (27%); a Stanford type B, in
4 (15%); an abdominal aortic aneurysm, in 2 (8%); a ductus
Botalli aneurysm, in 2 (8%); and an aberrant right subclavian ar-
tery aneurysm, in 1 (4%) (Table 2). The preoperative EuroSCORE
II was 18.19%.
The mean preoperative ascending TD in patients with an as-
cending aneurysm was 4.92 (r = 3.4–6.5; SD = 0.9) cm. The mean
preoperative arch/descending aorta diameter was 6.1 (r = 3–11;
SD = 2) cm.
Seventy-five supra-aortic vessels were debranched (mean of
2.9 vessels per patient) using the SADB technique: 13 (17%) BCTs;
9 (12%) right subclavian arteries; 15 (20%) right carotid arteries
(RCA); 25 (33%) left carotid arteries (LCAs); 12 (16%) LSAs; and 1
(1%) left vertebral artery. A standard end-to-side distal anasto-
mosis was performed in 26 (26/75; 35%) vessels; the VORTEC was
used for 48 (48/75; 64%) vessels and the GHVG, in 1 (1/75; 1%)
(Table 2).
The mean time interval to TEVAR after the WT/SADB was 29
(r = 0–204; SD = 48) days. In 9 (35%) cases, the WT/SADB and
TEVAR were performed simultaneously.
In addition to the treated vessels, TEVAR was accompanied by
CPGs in 6 (23%) patients to maintain blood flow into 6 LSAs and
1 BCT.
Six (23%) patients required additional surgery to maintain
blood flow into the supra-aortic branches (1 right carotid artery–
LCA–LSA bypass; 5 LCA–LSA bypasses). Three bypasses were per-
formed simultaneously with TEVAR and 3 cases between the WT/
SADB and TEVAR.
The perioperative mortality rate was 7.7% (2/26). One death
occurred immediately after TEVAR (case #8) due to massive myo-
cardial infarction. The second death (case #3) was registered on the
18th postoperative day due to respiratory insufficiency and spinal
cord ischaemia. Complications that were managed conservatively
were registered in 4 cases: 2 with myocardial infarction, both pre-
senting with precordial pain and increase of troponin level and, in
1 case, ST elevation; 2 with pulmonary embolism.
Neurological events were registered in 3 cases (amaurosis
fugax; transient ischaemic attack; transient spinal cord ischaemia).
Reinterventions were done in 3 cases: 1 due to pneumothorax
requiring drainage and 2 due to bleeding requiring revision. No
type A retrograde dissection was registered.
After the ascending WT, the mean ascending TD was 3.6
(r = 2.8–4.6; SD = 0.5) cm with a mean reduction of 1.3 (r = 0.5–
3.0; SD = 0.7) cm (P < 0.001). The ascending diameter remained
stable during the follow-up period in all cases (Table 2). At mean
follow-up, the arch/descending aorta diameter was 5.5 (r = 2.8–
10.4; SD = 10.4) cm with significant shrinkage (P = 0.001).
A slow flow type 1a endoleak [14] occurred in 1 (3.8%) patient
(case #23) after TEVAR and LSA chimney graft; the aneurysm sac
decreased postoperatively about 0.6 cm, and it is currently under
surveillance. A type III endoleak was registered in 2 cases; in case
#11 an increase in the aneurysm sac (1.5 cm) required a second-
ary intervention 27 months after the initial TEVAR. In case #26,
no aneurysm sac change was observed, and the patient is under
surveillance. In 4 cases (#6, #9, #15 and #18), a type II endoleak
with no enlargement of the aneurysm sac was registered.
The estimated rates for 5-year survival, freedom from cardio-
vascular reinterventions and SADB freedom from occlusion were
71.7, 82.3 and 96%, respectively (Fig. 4). Aortic valve function
during follow-up remained stable in all but 1 patient (case #4) in
whom implantation of the transapical aortic valve was planned
in advance and performed 6 months after the TEVAR.
DISCUSSION
Surgical repair of aortic arch diseases, especially when they in-
volve the ascending and/or descending aorta, may carry a high
surgical risk even in patients who are at low risk for general an-
aesthesia. Improvements in neurological protections and surgical
techniques have been reported over the years. However, a high
mortality rate up to 29% and neurological events up to 18% are
still reported [15–17].
Totally endovascular solutions with both fenestrated and
branched stent grafts have been proposed to land proximally in
Ishimaru zone 0. All of these devices are still under investigation
in high-risk patients [18]. In addition, the use of parallel grafts in
supra-aortic vessels has been reported with promising results
even in an emergent setting [19].
The presence of a dilated ascending aorta represents a limita-
tion to the full endovascular approach and zone 0 landing.
Generally, a dilated/aneurysmal ascending aorta precludes the
total endovascular approaches. In such patients, the gold stand-
ard is still conventional ascending and arch graft replacement.
Perioperative results of such surgery can be determined using the
EuroSCORE II calculator [3]. In more extensive disease, the opera-
tive risk is generally higher. LeMaire reported a 2% perioperative
mortality, 5% cerebral events and 77.6% 2-year survival rate for
patients with aneurysms involving the ascending aorta and the
aortic arch [20]. In their experience with the elephant trunk tech-
nique in patients presenting with more extensive aneurysmal dis-
ease, they observed a 16% overall operative mortality rate, 8%
neurological events and 70% 5-year survival rate [21].
SADB and TEVAR in zone 0 have been reported in patients
with a normal ascending aorta who are considered unfit for
Table 1: Demographic and clinical preoperative data
Number of patients 26
Mean age, years 72
Over 70 years, n (%) 11 (42)
Female, n (%) 9 (35)
Hypertension, n (%) 24 (85)
Pulmonary disease, n (%) 16 (61)
GOLD 1, n (%) 10 (38)
GOLD 2, n (%) 8 (31)
GOLD 3, n (%) 7 (27)
GOLD 4, n (%) 1 (4)
Cardiac disease, n (%) 15 (58)
Mild aortic valve insufficiency, n (%) 8 (31)
Mild valve stenosis, n (%) 1 (4)
Coronary artery disease, n (%) 6 (23)
NYHA I, n (%) 8 (31)
NYHA II, n (%) 10 (38)
NYHA III, n (%) 6 (23)
NYHA IV, n (%) 2 (8)
Lipid disorder, n (%) 8 (31)
Peripheral arterial disease, n (%) 6 (23)
Cancer, n (%) 6 (23)
Cerebral vascular disease, n (%) 10 (39)
Hostile chest, n (%) 8 (31)
Preoperative EuroSCORE II 18.19
GOLD: Global Initiative for Chronic Obstructive Lung Disease; NHYA:
New York Heart Association.
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Table 2: Patient aortic disease and surgical detail
ID Diagnosis WT SADB TEVAR
1 1. Ascendens an Polyester mesh 1. BCT-E/S 1. TAGa 37/20
2. Arch an Asc TDR: 9 mm 2. LCA-E/S
3. LSA-VORTEC
2 1. Ascendens an Polyester mesh 1. BCT-E/S 1. TAGa 34/20
2. Arch an Asc TDR: 7 mm 2. LCA-VORTEC
3. Thoracic an
3 1. Ascendens an Polyester mesh 1. BCT-E/S 1. TAGa 34/20
2. Crawford II TAAA Asc TDR: 12 mm 2. LCA-VORTEC
3. LSA-VORTEC
4 1. Ascendens an Polyester mesh 1. BCT-E/S 1. TAGa 34/20
2. Arch an Asc TDR: 7 mm 2. LCA-VORTEC
3. AAA
5 1. Crawford I TAAA Polypropylene mesh 1. RSA-E/S 1. TAGa 40/20
Asc TDR: 18 mm 2. RCA-E/S
3. LCA-VORTEC
4. LSA-VORTEC
6 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 40/20
2. B dissection Asc TDR: 20 mm 2. LCA-VORTEC
7 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. EVITAb 44-40/20
2. Arch an Asc TDR: 18 mm 2. RCA-VORTEC 2. EVITAb 40/15
3. LCA-VORTEC
4. LSA-VORTEC
8 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. TAGa 40/20
2. Crawford II TAAA Asc TDR: 12 mm 2. RCA-VORTEC 2. TAGa 40/20
3. LCA-VORTEC 3. TAGa 40/20
4. LSA-VORTEC
9 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 31/15
2. Thoracic an Asc TDR: 14 mm 2. RCA-VORTEC 2. TAGa 40/20
3. B dissection 3. LCA-VORTEC 3. TAGa 40/20
4. LSA-VORTEC 4. TAGa 40/20
10 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. TAGa 37/20
2. B dissection Asc TDR: 5 mm 2. RCA-VORTEC 2. TAGa 31/20
3. LCA-VORTEC
4. LSA-VORTEC
11 1. Ascendens an Polypropylene mesh 1. BCT-VORTEC 1. TAGa 37/20
2. Arch an Asc TDR: 30 mm 2. LCA-VORTEC 2. EVITAb 40/23
3. LVA-VORTEC
12 1. Ascendens an Polypropylene mesh 1. RSA-VORTEC 1. TAGa 34/37
2. Arch an Asc TDR: 8 mm 2. RCA-VORTEC
3. Thoracic an 3. LCA-VORTEC
13 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. TAGa 31/15
2. ARSA an Asc TDR: 6 mm 2. RCA-E/S
3. LCA-E/S
4. LSA-E/S
14 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. TAGa 37/15
2. Ductus Botalli an Asc TDR: 16 mm 2. RCA-VORTEC 2. TAGa 31/15
3. LCA-VORTEC
4. LSA-VORTEC
15 1. Ascendens an Polypropylene mesh 1. RCA-E/S 1. TAGa 34/20
2. Crawford II TAAA Asc TDR: 10 mm 2. LCA-VORTEC
16 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 40/15
Asc TDR: 8 mm 2. LCA-VORTEC
17 1. Ascendens an Polypropylene mesh 1. RCA-VORTEC 1. TAGa 34/20
2. Crawford II TAAA Asc TDR: 6 mm 2. LCA-VORTEC 2. TAGa 34/20
18 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 40/15
2. Crawford II TAAA Asc TDR: 19 mm 2. LCA-VORTEC 2. TAGa 40/15
3. LSA-VORTEC
19 1. Arch an Polypropylene mesh 1. RSA-E/S 1. TAGa 34/20
Asc TDR: 8 mm 2. RCA-VORTEC
3. LCA-VORTEC
20 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 45/15
2. Arch an Asc TDR: 9 mm 2. TAGa 45/15
3. Crawford II TAAA 3. TAGa 45/15
21 1. Arch an Polypropylene mesh 1. BCT-E/S 1. TAGa 37/20
2. Crawford II TAAA Asc TDR: 13 mm 2. RCA-VORTEC
3. B dissection 3. LCA-VORTEC
4. LSA-VORTEC
Continued
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conventional open repair [6, 22]. The WT/SADB followed by
TEVAR may be a less risky procedure compared to open graft re-
placement in patients presenting with dilation or aneurysm
(<70 mm) of the ascending aorta. The WT reduces and reinforces
the whole ascending aorta, allowing the best anastomosis site for
SADB and the best landing zone for TEVAR [23]. In addition,
reducing the aortic diameter decreases the aortic wall stress,
which may lower the risk of aortic dissection while clamping/
declamping the aorta during SADB or TEVAR in the ascending
aorta. The fact that no aortic dissection occurred during or after
WT/SADB and TEVAR seems to confirm our hypotheses.
Moreover, the WT has been shown to be effective and durable
over time in the treatment of isolated ascending aneurysms [9]. A
meta-analysis of ascending WTs showed in-hospital mortality
and mortality rates during the follow-up period of 1.5 and 0.3%,
respectively. Re-dilatations and reinterventions were observed in
1.7 and 1.8% in cases where the mesh was not sutured to the
aorta [24]. During the SADB, the aorta is tangentially clamped to
a section with a lower diameter after the ascending WT. It was
shown that after WT, shear stress is significantly reduced; there-
fore, the risk of plaque disruption, atheroembolization and aortic
dissection due to aortic clamp application is lower [25].
The VORTEC and the GHVG were used in 65% of the distal
anastomoses (49 supra-aortic vessels) to reduce the ischaemic
time, overall procedure time and bleeding sources from the
debranched vessels [10, 26]. The cost of the device represents a
relevant limitation of the VORTEC and GHVG.
The early and mid-term outcomes achieved with WAT/SADB/
TEVAR have a perioperative mortality and neurological events
rate of 7.7 and 11.5%, respectively; the estimated 5-year survival
rate of 71.7% is acceptable, especially considering that this ap-
proach was used in high-risk patients unfit for conventional
surgery.
In comparison, Preventza et al. reported their results with a
lower-risk cohort of 29 patients requiring a zone 0 TEVAR prox-
imal landing without ascending aorta involvement. In that series,
perioperative mortality was 6.9%; the neurological events rate
was 10.3% and the estimated 2-year survival rate was 79.3% [27].
As reported in case #24, the WT can be used in association
with fenestrated/branched stent grafts to expand their applica-
tion in patients presenting with an enlarged ascending aorta.
Basically, in our patients, the enlarged or aneurysmal ascend-
ing aorta required replacement (type II hybrid arch repair (HAR)),
but with the WT technique, the ascending aorta was made fit for
a stent graft landing (type I HAR). In a series including 36 patients
undergoing the type I–II HAR, results were similar to those with
WT/SADB-TEVAR, with a reported overall mortality rate of 8%,
14% permanent neurological events and 8% renal failure [28].
Severe aortic valve stenosis and insufficiency requiring valve re-
pair are limitations of the WT. Slight regurgitation, especially due
to a disturbance of the sinotubular junction, may be corrected
with the WT. If not, the approach depends on severity of regurgi-
tation and the general condition of the patient. Transcatheter
aortic valve implantation should be considered, especially in
cases of appropriate aortic annulus size. Coronary artery disease
is not an exclusion criterion for WT/SADB because it can be man-
aged off pump or by percutaneous coronary intervention [29].
The WT should be avoided in cases with an ascending aneur-
ysm larger than 70 mm because of the thinness of the arterial
wall and the related risk of the surgical exposure of the aorta and
the pulmonary artery [9]. Severe calcifications and/or visible pla-
ques are considered contraindications to the WT due to the risk
of plaque rupture during aortic mobilization and mesh
tightening.
Combining an LSA periscope graft, eventually as a sandwich,
into the repair strategy may be critical because it maintains
Table 2 Continued
ID Diagnosis WT SADB TEVAR
22 1. Ascendens an Polypropylene mesh 1. RSA-E/S 1. TAGa 45/20
2. Arch an Asc TDR: 24 mm 2. RCA-VORTEC
3. Thoracic an 3. LCA-VORTEC
4. LSA-VORTEC
23 1. Ascendens an Polypropylene mesh 1. BCT-VORTEC 1. TAGa 45/20
2. Arch an Asc TDR: 25 mm 2. LCA-GHVG
3. Crawford I TAAA
24 1. Ascendens an Polypropylene mesh 1. RCA-VORTEC 1. NEXUSc
2. Arch an Asc TDR: 10 mm 2. LCA-VORTEC
3. Thoracic an
25 1. Ascendens an Polypropylene mesh 1. BCT-E/S 1. TAGa 37/15
2. Arch an Asc TDR: 7 mm 2. LCA-VORTEC
3. Ductus Botalli an
26 1. Ascendens an Polypropylene mesh 1. RCA-VORTEC 1. TAGa 45/20
2. Arch an Asc TDR: 7 mm 2. LCA-E/S 2. TAGa 45/20
3. AAA
WT: wrapping technique; SADB: supra-aortic debranching; TEVAR: thoracic endovascular aneurysm repair; BCT: brachiocephalic trunk; RSA: right subclavian
artery; RCA: right carotid artery; LCA: left carotid artery; LSA: left subclavian artery; An: aneurysm; TAAA: thoraco-abdominal aneurysm; AAA: abdominal aortic
aneurysm; Asc TDR: ascending transverse diameter reduction; VORTEC: ViaBahn Open Revascularisation TEChnique; GHVG: Gore hybrid vascular graft.
aW.L. Gore & Associates, Flagstaff, AZ, USA.
bJotec, Hechingen, Germany.
cEndospan, Herzlia, Israel.
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transaxillary access to the abdominal aorta and the pelvic or
lower limb vessels. Although low, an increased risk of gutters and
endoleaks is possible [30].
The lack of a comparison group treated with conventional
open repair during the same period may represent a study limi-
tation. However, based on the positive outcomes achieved in this
high-risk population, it appears difficult to argue for an open sur-
gical approach.
In conclusion, the ascending aorta WT, SADB and TEVAR
used in high-risk patients presenting with complex, extensive
thoracic aorta aneurysms involving the ascending aorta
and considered unfit for conventional open graft replacement
showed promising early and mid-term results. These tech-
niques may be considered a valid alternative to conventional
open-heart surgery in this group of patients, especially if a
larger cohort of patients and a longer follow-up period validate
these data.
Conflict of interest: none declared.
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